UK consensus and NICE resources emphasise these mechanisms and management approaches
Diabetologia 56(7): 15031511 33
dulaglutide, NEJM, 2025 Semaglutide and cartilage regeneration Cell Metabolism, 2026 Lean mass loss with GLP-1 drugs systematic review, 2024 Retatrutide Phase 2 NEJM, 2023 Myostatin gene discovery McPherron et al., Nature, 1997 German myostatin-knockout child Schuelke et al., NEJM, 2004 Myostatin inhibitor history Nielsen et al., Cells, 2021 Micronutrient joint advisory Mozaffarian et al., 2025 Last Updated on June 20, 2026 by Joe Garma
[4] These medications are typically prescribed in conjunction with a reduced-calorie diet and increased physical activity, as part of a comprehensive weight management program such as ours here at Rivas medical Weight Loss Potential Benefits Beyond Glycemic Control While GLP-1 agonists are primarily used for blood sugar control and weight management in type 2 diabetes, they also show promise in providing additional health benefits
The sweet spot for most trials is between 3g and 6g daily, with or without a loading phase (5-10 days of higher creatine intake before reducing to around 3-6g daily).2 3 Some studies even use 10g of creatine, showing both muscle-building effects and the ability to improve cognition and general wellness.4 5 Those are pretty large doses, which is why so many creatine supplements are sold in powder form instead of as capsules
Wala, upholding a district courts application of the federal sentencing guidelines in a counterfeit drug prosecution under the Food, Drug, and Cosmetic Act
